호흡기용 내구 의료장비 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 지역별 및 부문별 예측(2026-2033년)

Respiratory Durable Medical Equipment Market Summary

The global respiratory durable medical equipment market size was valued at USD 48.0 billion in 2025 and is projected to grow from USD 50.4 billion in 2026 to USD 70.6 billion by 2033, at a CAGR of 4.9% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 41.0% in 2025. The significant factors contributing to market growth include the rising prevalence of chronic respiratory diseases, growing adoption of home mechanical ventilation, rising demand for portable respiratory equipment, and expansion of remote respiratory therapy monitoring.

Global Dental Braces Market Report Segmentation

This report forecasts revenue growth at global, regional & country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global dental braces market report based on component, material, placement, patient group, application, end-use, distribution channel, and region:

• Component Outlook (Revenue, USD Billion, 2021 - 2033)
• Brackets
• Conventional Brackets
• Self-Ligating Brackets
  • Passive Self-Ligating
  • Active Self-Ligating
• Archwires
• Ligatures / Elastomeric Modules
• Tubes & Bands
• Others
• Material Outlook (Revenue, USD Billion, 2021 - 2033)
• Stainless Steel
• Polycrystalline Ceramic
• Monocrystalline (Sapphire) Ceramic
• Nickel-Titanium
• Cobalt-Chromium
• Others
• Placement Outlook (Revenue, USD Billion, 2021 - 2033)
• Labial/Buccal
• Lingual
• Patient Group Outlook (Revenue, USD Billion, 2021 - 2033)
• Children (<12)
• Teenagers (12-17)
• Adults (18+)
• Application Outlook (Revenue, USD Billion, 2021 - 2033)
• Teeth Alignment
• Crowding & Spacing
• Bite Correction
• Arch Expansion
• Others
• End-use Outlook (Revenue, USD Billion, 2021 - 2033)
• Dental & Orthodontic Clinics
• Private Clinics
• DSO Affiliated
• Hospitals
• Academic & Research Institutions
• Distribution Channel Outlook (Revenue, USD Billion, 2021 - 2033)
• Direct Sales
• Indirect Sales
• Dental Distributors
• Medical Suppliers
• Online / E-commerce
• Regional Outlook (Revenue, USD Billion, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Thailand
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising Prevalence of Chronic Respiratory Diseases
    • 3.2.1.2. Growing Adoption of Home-Based Respiratory Care
    • 3.2.1.3. Technological Advancements in Portable and Connected Respiratory Equipment
    • 3.2.1.4. Increasing Demand for Sleep Apnea Management Devices
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High Cost of Advanced Respiratory DME
    • 3.2.2.2. Reimbursement and Coverage Limitations
  • 3.2.3. Industry Opportunity Analysis
  • 3.2.4. Industry Challenge Analysis
  • 3.2.5. Technology Overview
• 3.3. Business Environment Analysis
  • 3.3.1. Porter's Five Forces Analysis
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTLE Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic and Social landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Environmental landscape
    • 3.3.2.5. Legal Landscape

Chapter 4. Global Respiratory Durable Medical Equipment Market: Product Estimates & Trend Analysis

• 4.1. Product Segment Dashboard
• 4.2. Product Market Share Movement Analysis, 2025 & 2033
• 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2021 to 2033 (USD Million)
• 4.4. Sleep Apnea Devices
  • 4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.2. Auto-titrating CPAP (APAP)
    • 4.4.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.3. Fixed CPAP
    • 4.4.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3.2. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.4. BiPAP / VPAP
    • 4.4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.5. Integrated Humidifiers
    • 4.4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Oxygen Therapy
  • 4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.2. Stationary Oxygen Concentrators
    • 4.5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.3. Portable Oxygen Concentrators (POCs)
    • 4.5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.4. Cylinders & Regulators
    • 4.5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.5. Conservers
    • 4.5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Nebulizer Equipment
  • 4.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6.2. Compressor Nebulizers
    • 4.6.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6.3. Mesh Nebulizers
    • 4.6.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6.4. Drug-specific nebulizers
    • 4.6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.7. Home & Transport Ventilators
  • 4.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7.2. Adult/pediatric long-term home ventilators
    • 4.7.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7.3. Portable Transport Ventilators
    • 4.7.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.8. Masks, Tubing, Filters & Resupply Items (Consumables)
  • 4.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8.2. CPAP masks
    • 4.8.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8.3. CPAP cushions
    • 4.8.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8.4. Oxygen tubing & filters
    • 4.8.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8.5. Humidifier chambers
    • 4.8.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8.6. Bacterial/viral filters
    • 4.8.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8.7. Aerosol delivery accessories
    • 4.8.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Global Respiratory Durable Medical Equipment Market: Regional Estimates & Trend Analysis

• 5.1. Regional Market Dashboard
• 5.2. Regional Market: Key Takeaways
• 5.3. North America
  • 5.3.1. North America respiratory durable medical equipment market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.3.2. U.S.
    • 5.3.2.1. Key country dynamic
    • 5.3.2.2. Regulatory framework
    • 5.3.2.3. Competitive insights
    • 5.3.2.4. U.S. respiratory durable medical equipment market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.3.3. Canada
    • 5.3.3.1. Key country dynamic
    • 5.3.3.2. Regulatory framework
    • 5.3.3.3. Competitive insights
    • 5.3.3.4. Canada respiratory durable medical equipment market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.3.4. Mexico
    • 5.3.4.1. Key country dynamic
    • 5.3.4.2. Regulatory framework
    • 5.3.4.3. Competitive insights
    • 5.3.4.4. Mexico respiratory durable medical equipment market estimates and forecasts, 2021 - 2033 (USD Million)
• 5.4. Europe
  • 5.4.1. Europe respiratory durable medical equipment market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.4.2. Germany
    • 5.4.2.1. Key country dynamic
    • 5.4.2.2. Regulatory framework
    • 5.4.2.3. Competitive insights
    • 5.4.2.4. Germany respiratory durable medical equipment market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.4.3. UK
    • 5.4.3.1. Key country dynamic
    • 5.4.3.2. Regulatory framework
    • 5.4.3.3. Competitive insights
    • 5.4.3.4. UK respiratory durable medical equipment market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.4.4. France
    • 5.4.4.1. Key country dynamic
    • 5.4.4.2. Regulatory framework
    • 5.4.4.3. Competitive insights
    • 5.4.4.4. France respiratory durable medical equipment market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.4.5. Italy
    • 5.4.5.1. Key country dynamic
    • 5.4.5.2. Regulatory framework
    • 5.4.5.3. Competitive insights
    • 5.4.5.4. Italy respiratory durable medical equipment market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.4.6. Spain
    • 5.4.6.1. Key country dynamic
    • 5.4.6.2. Regulatory framework
    • 5.4.6.3. Competitive insights
    • 5.4.6.4. Spain respiratory durable medical equipment market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.4.7. Denmark
    • 5.4.7.1. Key country dynamic
    • 5.4.7.2. Regulatory framework
    • 5.4.7.3. Competitive insights
    • 5.4.7.4. Denmark respiratory durable medical equipment market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.4.8. Sweden
    • 5.4.8.1. Key country dynamic
    • 5.4.8.2. Regulatory framework
    • 5.4.8.3. Competitive insights
    • 5.4.8.4. Sweden respiratory durable medical equipment market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.4.9. Norway
    • 5.4.9.1. Key country dynamic
    • 5.4.9.2. Regulatory framework
    • 5.4.9.3. Competitive insights
    • 5.4.9.4. Norway respiratory durable medical equipment market estimates and forecasts, 2021 - 2033 (USD Million)
• 5.5. Asia Pacific
  • 5.5.1. Asia Pacific respiratory durable medical equipment market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.5.2. Japan
    • 5.5.2.1. Key country dynamic
    • 5.5.2.2. Regulatory framework
    • 5.5.2.3. Competitive insights
    • 5.5.2.4. Japan respiratory durable medical equipment market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.5.3. China
    • 5.5.3.1. Key country dynamic
    • 5.5.3.2. Regulatory framework
    • 5.5.3.3. Competitive insights
    • 5.5.3.4. China respiratory durable medical equipment market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.5.4. India
    • 5.5.4.1. Key country dynamic
    • 5.5.4.2. Regulatory framework
    • 5.5.4.3. Competitive insights
    • 5.5.4.4. India respiratory durable medical equipment market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.5.5. South Korea
    • 5.5.5.1. Key country dynamic
    • 5.5.5.2. Regulatory framework
    • 5.5.5.3. Competitive insights
    • 5.5.5.4. South Korea respiratory durable medical equipment market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.5.6. Australia
    • 5.5.6.1. Key country dynamic
    • 5.5.6.2. Regulatory framework
    • 5.5.6.3. Competitive insights
    • 5.5.6.4. Australia respiratory durable medical equipment market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.5.7. Thailand
    • 5.5.7.1. Key country dynamic
    • 5.5.7.2. Regulatory framework
    • 5.5.7.3. Competitive insights
    • 5.5.7.4. Thailand respiratory durable medical equipment market estimates and forecasts, 2021 - 2033 (USD Million)
• 5.6. Latin America
  • 5.6.1. Latin America Respiratory Durable Medical Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6.2. Brazil
    • 5.6.2.1. Key country dynamic
    • 5.6.2.2. Regulatory framework
    • 5.6.2.3. Competitive insights
    • 5.6.2.4. Brazil respiratory durable medical equipment market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.6.3. Argentina
    • 5.6.3.1. Key country dynamic
    • 5.6.3.2. Regulatory framework
    • 5.6.3.3. Competitive insights
    • 5.6.3.4. Argentina respiratory durable medical equipment market estimates and forecasts, 2021 - 2033 (USD Million)
• 5.7. MEA
  • 5.7.1. MEA respiratory durable medical equipment market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.7.2. South Africa
    • 5.7.2.1. Key country dynamic
    • 5.7.2.2. Regulatory framework
    • 5.7.2.3. Competitive insights
    • 5.7.2.4. South Africa respiratory durable medical equipment market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.7.3. Saudi Arabia
    • 5.7.3.1. Key country dynamic
    • 5.7.3.2. Regulatory framework
    • 5.7.3.3. Competitive insights
    • 5.7.3.4. Saudi Arabia respiratory durable medical equipment market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.7.4. UAE
    • 5.7.4.1. Key country dynamic
    • 5.7.4.2. Regulatory framework
    • 5.7.4.3. Competitive insights
    • 5.7.4.4. UAE respiratory durable medical equipment market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.7.5. Kuwait
    • 5.7.5.1. Key country dynamic
    • 5.7.5.2. Regulatory framework
    • 5.7.5.3. Competitive insights
    • 5.7.5.4. Kuwait respiratory durable medical equipment market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. Competitive Landscape

• 6.1. Participant Overview
• 6.2. Company Market Position Analysis/Company Market Share Analysis (2025)
• 6.3. Company Categorization
• 6.4. Strategy Mapping
• 6.5. Company Profiles/Listing
  • 6.5.1. ResMed Inc.
    • 6.5.1.1. Overview
    • 6.5.1.2. Financial performance
    • 6.5.1.3. Product benchmarking
    • 6.5.1.4. Strategic initiatives
  • 6.5.2. Koninklijke Philips N.V.
    • 6.5.2.1. Overview
    • 6.5.2.2. Financial performance
    • 6.5.2.3. Product benchmarking
    • 6.5.2.4. Strategic initiatives
  • 6.5.3. Fisher & Paykel Healthcare Limited
    • 6.5.3.1. Overview
    • 6.5.3.2. Financial performance
    • 6.5.3.3. Product benchmarking
    • 6.5.3.4. Strategic initiatives
  • 6.5.4. Drive DeVilbiss International
    • 6.5.4.1. Overview
    • 6.5.4.2. Financial performance
    • 6.5.4.3. Product benchmarking
    • 6.5.4.4. Strategic initiatives
  • 6.5.5. Invacare Corporation
    • 6.5.5.1. Overview
    • 6.5.5.2. Financial performance
    • 6.5.5.3. Product benchmarking
    • 6.5.5.4. Strategic initiatives
  • 6.5.6. Inogen
    • 6.5.6.1. Overview
    • 6.5.6.2. Financial performance
    • 6.5.6.3. Product benchmarking
    • 6.5.6.4. Strategic initiatives
  • 6.5.7. React Health, Inc.
    • 6.5.7.1. Overview
    • 6.5.7.2. Financial performance
    • 6.5.7.3. Product benchmarking
    • 6.5.7.4. Strategic initiatives
  • 6.5.8. Breas Medical AB
    • 6.5.8.1. Overview
    • 6.5.8.2. Financial performance
    • 6.5.8.3. Product benchmarking
    • 6.5.8.4. Strategic initiatives
  • 6.5.9. Medtronic
    • 6.5.9.1. Overview
    • 6.5.9.2. Financial performance
    • 6.5.9.3. Product benchmarking
    • 6.5.9.4. Strategic initiatives
  • 6.5.10. Dragerwerk AG & Co. KGaA
    • 6.5.10.1. Overview
    • 6.5.10.2. Financial performance
    • 6.5.10.3. Product benchmarking
    • 6.5.10.4. Strategic initiatives
  • 6.5.11. Hamilton Medical AG
    • 6.5.11.1. Overview
    • 6.5.11.2. Financial performance
    • 6.5.11.3. Product benchmarking
    • 6.5.11.4. Strategic initiatives
  • 6.5.12. Getinge AB
    • 6.5.12.1. Overview
    • 6.5.12.2. Financial performance
    • 6.5.12.3. Product benchmarking
    • 6.5.12.4. Strategic initiatives
  • 6.5.13. GE HealthCare
    • 6.5.13.1. Overview
    • 6.5.13.2. Financial performance
    • 6.5.13.3. Product benchmarking
    • 6.5.13.4. Strategic initiatives
  • 6.5.14. Chart Industries, Inc.
    • 6.5.14.1. Overview
    • 6.5.14.2. Financial performance
    • 6.5.14.3. Product benchmarking
    • 6.5.14.4. Strategic initiatives
  • 6.5.15. CAIRE Inc. (Niterra Co., Ltd.)
    • 6.5.15.1. Overview
    • 6.5.15.2. Financial performance
    • 6.5.15.3. Product benchmarking
    • 6.5.15.4. Strategic initiatives
  • 6.5.16. OMRON Healthcare, Inc.
    • 6.5.16.1. Overview
    • 6.5.16.2. Financial performance
    • 6.5.16.3. Product benchmarking
    • 6.5.16.4. Strategic initiatives
  • 6.5.17. Yuwell (Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.)
    • 6.5.17.1. Overview
    • 6.5.17.2. Financial performance
    • 6.5.17.3. Product benchmarking
    • 6.5.17.4. Strategic initiatives
  • 6.5.18. BMC Medical Co., Ltd.
    • 6.5.18.1. Overview
    • 6.5.18.2. Financial performance
    • 6.5.18.3. Product benchmarking
    • 6.5.18.4. Strategic initiatives
  • 6.5.19. Apex Medical Corp.
    • 6.5.19.1. Overview
    • 6.5.19.2. Financial performance
    • 6.5.19.3. Product benchmarking
    • 6.5.19.4. Strategic initiatives
  • 6.5.20. PARI GmbH
    • 6.5.20.1. Overview
    • 6.5.20.2. Financial performance
    • 6.5.20.3. Product benchmarking
    • 6.5.20.4. Strategic initiatives
  • 6.5.21. GCE Group
    • 6.5.21.1. Overview
    • 6.5.21.2. Financial performance
    • 6.5.21.3. Product benchmarking
    • 6.5.21.4. Strategic initiatives